WallStreetZenWallStreetZen

NASDAQ: HUGE
Fsd Pharma Inc Stock

$1.16+0.01 (+0.87%)
Updated Feb 3, 2023
HUGE Price
$1.16
Fair Value Price
$1.78
Market Cap
$44.21M
52 Week Low
$0.62
52 Week High
$1.18
P/E
-2.69x
P/B
1.68x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$18.03M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.21
Operating Cash Flow
-$20M
Beta
1.07
Next Earnings
Mar 29, 2023
Ex-Dividend
N/A
Next Dividend
N/A

HUGE Overview

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how HUGE scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

HUGE ($1.16) is undervalued by 34.89% relative to our estimate of its Fair Value price of $1.78 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
HUGE ($1.16) is significantly undervalued by 34.89% relative to our estimate of its Fair Value price of $1.78 based on Discounted Cash Flow (DCF) modelling, which includes a healthy margin of safety
Significantly Below Fair Value Valuation
HUGE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 30 more HUGE due diligence checks available for Premium users.

Be the first to know about important HUGE news, forecast changes, insider trades & much more!

HUGE News

Valuation

HUGE fair value

Fair Value of HUGE stock based on Discounted Cash Flow (DCF)
Price
$1.16
Fair Value
$1.78
Undervalued by
34.89%
HUGE ($1.16) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
HUGE ($1.16) is significantly undervalued... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
HUGE is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

HUGE price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-2.69x
Industry
18.24x
Market
15.09x

HUGE price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.68x
Industry
1.9x
HUGE is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

HUGE's financial health

Profit margin

Revenue
$0.0
Net Income
-$5.4M
Profit Margin
0%
HUGE's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$33.0M
Liabilities
$5.6M
Debt to equity
0.21
HUGE's short-term assets ($18.36M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
HUGE's short-term assets ($18.36M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
HUGE's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$5.7M
Investing
-$73.4k
Financing
-$195.3k
HUGE's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

HUGE vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
HUGE$44.21M+0.96%-2.69x1.68x
CRDL$45.00M+1.72%-2.16x1.05x
DERM$43.38M+9.38%-0.82x1.66x
TXMD$49.23M-0.95%-5.25x-1.02x
CPIX$37.46M-0.38%-5.51x0.97x

Fsd Pharma Stock FAQ

What is Fsd Pharma's quote symbol?

NASDAQ: HUGE) Fsd Pharma trades on the NASDAQ under the ticker symbol HUGE. Fsd Pharma stock quotes can also be displayed as NASDAQ: HUGE.

If you're new to stock investing, here's how to buy Fsd Pharma stock.

What is the 52 week high and low for Fsd Pharma (NASDAQ: HUGE)?

(NASDAQ: HUGE) Fsd Pharma's 52-week high was $1.18, and its 52-week low was $0.62. It is currently -1.69% from its 52-week high and 87.7% from its 52-week low.

How much is Fsd Pharma stock worth today?

(NASDAQ: HUGE) Fsd Pharma currently has 38,114,282 outstanding shares. With Fsd Pharma stock trading at $1.16 per share, the total value of Fsd Pharma stock (market capitalization) is $44.21M.

Fsd Pharma stock was originally listed at a price of $7.58 in Jan 9, 2020. If you had invested in Fsd Pharma stock at $7.58, your return over the last 3 years would have been -84.7%, for an annualized return of -46.51% (not including any dividends or dividend reinvestments).

How much is Fsd Pharma's stock price per share?

(NASDAQ: HUGE) Fsd Pharma stock price per share is $1.16 today (as of Feb 3, 2023).

What is Fsd Pharma's Market Cap?

(NASDAQ: HUGE) Fsd Pharma's market cap is $44.21M, as of Feb 6, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Fsd Pharma's market cap is calculated by multiplying HUGE's current stock price of $1.16 by HUGE's total outstanding shares of 38,114,282.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.